Largest Biotechnology Companies by Market Cap
Largest Biotechnology companies by market cap. The Biotechnology sector has 1,295 publicly listed stocks with a combined market cap of $2.06 Trillion. Oncolytics Biotech Inc leads the sector with a market cap of $142.51 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
Companies Listed
Largest Company
Top Biotechnology Stocks by Market Capitalization (October 2026)
Top Biotechnology stocks by market capitalization as of October 2026, covering 1,295 publicly listed companies.
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 601 |
Oncolytics Biotech Inc
TO:ONC |
$142.51 Million | CA$197.01 Million | Canada | CA$14.90 | +0.00% | +0.00% | 280.00 |
| 602 |
PROQR THERAPEUTICS EO-04
F:0PQ |
$142.34 Million | €121.75 Million | Germany | €1.22 | +4.82% | +2.52% | 0.00 |
| 603 |
Zentalis Pharmaceuticals Llc
NASDAQ:ZNTL |
$141.66 Million | $141.66 Million | USA | $1.99 | -3.40% | -15.68% | 35.61 Million |
| 604 |
Whitehawk Therapeutics, Inc.
NASDAQ:WHWK |
$141.39 Million | $141.39 Million | USA | $3.30 | -4.62% | +0.46% | 8.09 Million |
| 605 |
TIZIANA LIFE SCIENCES LTD
F:0RP |
$141.34 Million | €120.90 Million | Germany | €0.95 | -2.56% | -9.52% | 68.00K |
| 606 |
NovaBridge Biosciences
NASDAQ:NBP |
$140.36 Million | $140.36 Million | USA | $1.21 | -3.97% | -11.68% | 9.91 Million |
| 607 |
Prelude Therapeutics Inc
NASDAQ:PRLD |
$140.19 Million | $140.19 Million | USA | $4.10 | -0.97% | +12.33% | 11.42 Million |
| 608 |
Panion & BF Biotech Inc
TW:1760 |
$139.92 Million | NT$4.44 Billion | Taiwan | NT$51.80 | -0.38% | -1.89% | 2.27 Million |
| 609 |
Jyong Biotech Ltd. Ordinary Shares
NASDAQ:MENS |
$139.56 Million | $139.56 Million | USA | $1.88 | -8.29% | -0.53% | 972.16K |
| 610 |
Coherus BioSciences Inc
NASDAQ:CHRS |
$138.80 Million | $138.80 Million | USA | $0.90 | -22.55% | -11.92% | 36.56 Million |
| 611 |
Avalo Therapeutics Inc
NASDAQ:AVTX |
$137.73 Million | $137.73 Million | USA | $7.44 | +4.49% | -39.31% | 59.89 Million |
| 612 |
Compass Therapeutics Inc.
NASDAQ:CMPX |
$136.18 Million | $136.18 Million | USA | $0.76 | -0.54% | -7.16% | 118.02 Million |
| 613 |
GREEN CROSS WellBeing Corporation
KQ:234690 |
$135.29 Million | ₩199.63 Billion | Korea | ₩11250.00 | -0.18% | +3.31% | 8.01 Million |
| 614 |
Spruce Biosciences, Inc. Common Stock
NASDAQ:SPRB |
$134.56 Million | $134.56 Million | USA | $46.82 | -0.36% | +9.57% | 1.85 Million |
| 615 |
Innate Pharma
NASDAQ:IPHA |
$133.24 Million | $133.24 Million | USA | $1.50 | -1.32% | -4.46% | 782.05K |
| 616 |
MOLECULAR PARTNERS ADS/1
F:6ML0 |
$133.19 Million | €113.92 Million | Germany | €3.54 | -3.80% | +0.00% | 17.40K |
| 617 |
Fate Therapeutics Inc
NASDAQ:FATE |
$131.50 Million | $131.50 Million | USA | $2.17 | +0.00% | +4.83% | 29.51 Million |
| 618 |
Tharimmune Inc.
NASDAQ:THAR |
$130.84 Million | $130.84 Million | USA | $3.31 | -5.70% | +0.00% | 15.04 Million |
| 619 |
VYTRUS BIOTECH EO -01
F:V5P |
$128.53 Million | €109.94 Million | Germany | €14.75 | -0.67% | +6.88% | 6.00 |
| 620 |
Atrium Therapeutics, Inc. Common Stock
NASDAQ:RNA |
$128.15 Million | $128.15 Million | USA | $8.26 | -1.67% | +3.25% | 6.19 Million |
| 621 |
TuHURA Biosciences Inc
NASDAQ:HURA |
$128.09 Million | $128.09 Million | USA | $2.06 | +3.52% | -1.20% | 8.15 Million |
| 622 |
Molecular Partners AG
SW:MOLN |
$127.56 Million | CHF100.89 Million | Switzerland | CHF2.99 | -0.33% | -1.64% | 292.52K |
| 623 |
Vytrus Biotech S.A.
MC:VYT |
$127.42 Million | €108.99 Million | Spain | €14.50 | -4.29% | +1.40% | 56.03K |
| 624 |
Alpha Cognition Inc
NASDAQ:ACOG |
$127.19 Million | $127.19 Million | USA | $9.19 | +0.22% | +7.11% | 2.42 Million |
| 625 |
InflaRx N.V
F:IF0 |
$126.95 Million | €108.58 Million | Germany | €1.50 | +4.60% | +9.64% | 43.92K |
| 626 |
Hyloris Developmentsen Sa
BR:HYL |
$126.36 Million | €108.08 Million | Belgium | €3.86 | +5.75% | -1.03% | 194.89K |
| 627 |
Nykode Therapeutics ASA
OL:NYKD |
$124.43 Million | Nkr1.18 Billion | Norway | Nkr3.02 | -1.31% | -9.04% | 24.20 Million |
| 628 |
Foghorn Therapeutics Inc
NASDAQ:FHTX |
$124.12 Million | $124.12 Million | USA | $2.09 | -1.88% | +2.45% | 30.53 Million |
| 629 |
Sensorion SA
PA:ALSEN |
$122.13 Million | €104.47 Million | France | €8.90 | +1.14% | -3.37% | 566.36K |
| 630 |
Kangstem Biotech Co. Ltd
KQ:217730 |
$121.04 Million | ₩178.61 Billion | Korea | ₩1899.00 | +1.93% | -3.41% | 6.01 Million |
| 631 |
Anavex Life Sciences Corp
NASDAQ:AVXL |
$120.51 Million | $120.51 Million | USA | $1.30 | +0.00% | -4.41% | 34.29 Million |
| 632 |
Inhibikase Therapeutics Inc
NASDAQ:IKT |
$119.23 Million | $119.23 Million | USA | $1.67 | +3.09% | +0.60% | 15.95 Million |
| 633 |
Nkarta Inc
NASDAQ:NKTX |
$118.90 Million | $118.90 Million | USA | $1.66 | -3.49% | -5.14% | 23.00 Million |
| 634 |
Vaxart Inc
NASDAQ:VXRT |
$118.57 Million | $118.57 Million | USA | $0.49 | +0.00% | +0.00% | 4.26 Million |
| 635 |
INNATE PHARMA SP.ADR/1
F:IDDA |
$116.15 Million | €99.35 Million | Germany | €1.06 | -9.40% | -26.90% | 6.23K |
| 636 |
Leap Therapeutics Inc
NASDAQ:LPTX |
$116.14 Million | $116.14 Million | USA | $2.05 | +368.57% | +391.14% | 793.17 Million |
| 637 |
Innate Pharma
PA:IPH |
$115.22 Million | €98.56 Million | France | €1.29 | +0.63% | -4.60% | 5.07 Million |
| 638 |
Tiziana Life Sciences Ltd
NASDAQ:TLSA |
$115.13 Million | $115.13 Million | USA | $0.90 | -4.77% | -10.43% | 12.97 Million |
| 639 |
Genovate Biotechnology Co Ltd
TWO:4130 |
$115.03 Million | NT$3.65 Billion | Taiwan | NT$26.70 | -0.37% | -5.15% | 4.08 Million |
| 640 |
Arcticzymes Technologies ASA
OL:AZT |
$115.01 Million | Nkr1.09 Billion | Norway | Nkr21.40 | +0.94% | +5.94% | 924.24K |
| 641 |
Heidelberg Pharma AG
F:HPHA |
$114.31 Million | €97.78 Million | Germany | €2.09 | +0.00% | -2.34% | 2.00K |
| 642 |
Repare Therapeutics Inc
NASDAQ:RPTX |
$114.24 Million | $114.24 Million | USA | $2.65 | +0.76% | +2.71% | 37.69 Million |
| 643 |
Ryvu Therapeutics SA
WAR:RVU |
$113.26 Million | zł411.54 Million | Poland | zł17.80 | -2.31% | +2.42% | 568.89K |
| 644 |
Codexis Inc
NASDAQ:CDXS |
$110.20 Million | $110.20 Million | USA | $1.22 | -3.17% | -5.43% | 20.11 Million |
| 645 |
LENZ Therapeutics Inc
NASDAQ:LENZ |
$109.66 Million | $109.66 Million | USA | $3.49 | +8.72% | +8.39% | 22.48 Million |
| 646 |
NIBEC Co. Ltd
KQ:138610 |
$109.24 Million | ₩161.20 Billion | Korea | ₩14180.00 | -2.74% | -9.16% | 829.63K |
| 647 |
Alterity Therapeutics Ltd
AU:ATH |
$108.75 Million | AU$153.70 Million | Australia | AU$0.26 | +8.33% | +1.96% | 10.80 Million |
| 648 |
SYN-Tech Chem & Pharm Co Ltd
TWO:1777 |
$107.47 Million | NT$3.41 Billion | Taiwan | NT$76.50 | +1.73% | +1.46% | 1.10 Million |
| 649 |
Seer Inc
NASDAQ:SEER |
$107.42 Million | $107.42 Million | USA | $1.94 | -2.51% | -4.43% | 6.04 Million |
| 650 |
Black Diamond Therapeutics Inc
NASDAQ:BDTX |
$106.86 Million | $106.86 Million | USA | $1.86 | +1.64% | -10.58% | 20.25 Million |
| 651 |
Gossamer Bio Inc
NASDAQ:GOSS |
$106.47 Million | $106.47 Million | USA | $10.69 | +0.00% | +9.19% | 6.20 Million |
| 652 |
Immunic Inc
NASDAQ:IMUX |
$106.18 Million | $106.18 Million | USA | $7.80 | -2.32% | +4.21% | 10.03 Million |
| 653 |
OnKure Therapeutics, Inc.
NASDAQ:OKUR |
$106.10 Million | $106.10 Million | USA | $2.62 | -0.38% | +13.91% | 10.80 Million |
| 654 |
Hillevax Inc
NASDAQ:HLVX |
$104.76 Million | $104.76 Million | USA | $2.09 | +0.00% | +0.00% | 0.00 |
| 655 |
Unicycive Therapeutics Inc
NASDAQ:UNCY |
$104.37 Million | $104.37 Million | USA | $3.81 | +1.33% | -1.55% | 26.41 Million |
| 656 |
Minerva Neurosciences Inc
NASDAQ:NERV |
$104.36 Million | $104.36 Million | USA | $2.24 | +1.36% | -6.28% | 3.26 Million |
| 657 |
Humacyte Inc
NASDAQ:HUMA |
$104.30 Million | $104.30 Million | USA | $0.47 | -0.06% | +14.25% | 144.27 Million |
| 658 |
vTv Therapeutics Inc
NASDAQ:VTVT |
$103.90 Million | $103.90 Million | USA | $26.38 | +2.57% | -5.01% | 688.41K |
| 659 |
Cibus Global LLC
NASDAQ:CBUS |
$103.18 Million | $103.18 Million | USA | $1.35 | -4.26% | -4.26% | 2.51 Million |
| 660 |
Vivani Medical Inc.
NASDAQ:VANI |
$102.83 Million | $102.83 Million | USA | $1.14 | +0.00% | -1.72% | 3.72 Million |
| 661 |
Orthocell Ltd
AU:OCC |
$102.70 Million | AU$145.15 Million | Australia | AU$0.54 | -0.93% | -10.83% | 13.21 Million |
| 662 |
enGene Holdings Inc. Common Stock
NASDAQ:ENGN |
$102.53 Million | $102.53 Million | USA | $1.53 | -3.16% | -6.13% | 19.05 Million |
| 663 |
Fractyl Health, Inc. Common Stock
NASDAQ:GUTS |
$101.88 Million | $101.88 Million | USA | $0.99 | +11.40% | -13.78% | 36.68 Million |
| 664 |
SynAct Pharma AB
ST:SYNACT |
$101.00 Million | Skr938.53 Million | Sweden | Skr16.76 | -4.12% | -3.90% | 1.70 Million |
| 665 |
MEI Pharma Inc
NASDAQ:MEIP |
$100.81 Million | $100.81 Million | USA | $3.07 | +0.00% | +0.00% | 4.03 Million |
| 666 |
STARPHARMA HLDG.SP.ADR/10
F:PQ6A |
$99.13 Million | €84.79 Million | Germany | €4.40 | -3.51% | +20.22% | 0.00 |
| 667 |
ORIENTBIO Inc.
KO:002630 |
$98.76 Million | ₩145.74 Billion | Korea | ₩1229.00 | -4.58% | -14.59% | 1.47 Million |
| 668 |
Voyager Therapeutics Inc
NASDAQ:VYGR |
$97.86 Million | $97.86 Million | USA | $1.76 | -4.35% | -12.87% | 22.95 Million |
| 669 |
Actinogen Medical Ltd
AU:ACW |
$96.71 Million | AU$136.67 Million | Australia | AU$0.04 | +7.50% | -10.42% | 115.56 Million |
| 670 |
Adverum Biotechnologies Inc
NASDAQ:ADVM |
$96.26 Million | $96.26 Million | USA | $4.36 | +0.00% | +3.81% | 11.22 Million |
| 671 |
Sagittarius Life Science
TWO:3205 |
$96.19 Million | NT$3.05 Billion | Taiwan | NT$45.20 | -1.74% | -3.73% | 442.17K |
| 672 |
Anixa Biosciences Inc
NASDAQ:ANIX |
$95.95 Million | $95.95 Million | USA | $3.30 | -2.08% | +21.77% | 5.79 Million |
| 673 |
Infant Bacterial Therapeutics AB (publ)
ST:IBT-B |
$95.69 Million | Skr889.14 Million | Sweden | Skr68.30 | +0.59% | -15.47% | 231.63K |
| 674 |
Immunoprecise Antibodies Ltd
NASDAQ:IPA |
$95.54 Million | $95.54 Million | USA | $2.07 | +0.00% | +0.00% | 1.97 Million |
| 675 |
Genelux Corporation Common Stock
NASDAQ:GNLX |
$94.16 Million | $94.16 Million | USA | $2.10 | -4.98% | +1.45% | 9.59 Million |
| 676 |
Cellectis
PA:ALCLS |
$93.69 Million | €80.14 Million | France | €1.10 | -2.30% | +10.75% | 8.43 Million |
| 677 |
Apex Biotechnology Corp
TW:1733 |
$93.68 Million | NT$2.97 Billion | Taiwan | NT$29.75 | +0.17% | -0.83% | 2.07 Million |
| 678 |
Coya Therapeutics, Inc. Common Stock
NASDAQ:COYA |
$93.36 Million | $93.36 Million | USA | $3.98 | -1.97% | -3.86% | 3.01 Million |
| 679 |
aTyr Pharma, Inc.
NASDAQ:ATYR |
$92.79 Million | $92.79 Million | USA | $5.37 | +4.56% | +3016.66% | 51.02 Million |
| 680 |
Polaryx Therapeutics, Inc. Common Stock
NASDAQ:PLYX |
$92.71 Million | $92.71 Million | USA | $1.86 | -1.59% | -4.12% | 659.20K |
| 681 |
Intech Biopharm Ltd
TWO:6461 |
$91.76 Million | NT$2.91 Billion | Taiwan | NT$26.40 | -0.56% | -5.21% | 3.30 Million |
| 682 |
CANBRIDGE PHARM.DL-00001
F:MF1 |
$91.43 Million | €78.20 Million | Germany | €0.15 | -1.29% | -21.54% | 0.00 |
| 683 |
Dimerix Ltd
AU:DXB |
$91.34 Million | AU$129.09 Million | Australia | AU$0.22 | +4.88% | +2.38% | 12.04 Million |
| 684 |
Paradigm Biopharmaceuticals Ltd
AU:PAR |
$91.09 Million | AU$128.74 Million | Australia | AU$0.25 | +0.00% | +0.00% | 0.00 |
| 685 |
Equillium Inc
NASDAQ:EQ |
$90.04 Million | $90.04 Million | USA | $1.42 | +0.00% | +0.00% | 15.92 Million |
| 686 |
Solux Co. Ltd
KQ:290690 |
$89.76 Million | ₩132.46 Billion | Korea | ₩2685.00 | -0.56% | -8.83% | 17.81 Million |
| 687 |
BIOCELTIX S.A. ZY -10
F:XI3 |
$89.73 Million | €76.75 Million | Germany | €20.40 | +6.36% | +10.39% | 0.00 |
| 688 |
Eastwood Bio-Medical Canada Inc
V:EBM |
$89.55 Million | CA$123.80 Million | Canada | CA$1.90 | -2.56% | +12.43% | 86.15K |
| 689 |
Biosolution Co.Ltd
KQ:086820 |
$89.29 Million | ₩131.75 Billion | Korea | ₩5460.00 | -2.33% | -7.30% | 1.44 Million |
| 690 |
ImmuCell Corporation
NASDAQ:ICCC |
$88.55 Million | $88.55 Million | USA | $10.32 | -2.82% | -1.90% | 208.81K |
| 691 |
Terns Pharmaceuticals Inc
NASDAQ:TERN |
$87.01 Million | $87.01 Million | USA | $0.80 | +0.00% | +63.27% | 80.93 Million |
| 692 |
Pyxis Oncology Inc
NASDAQ:PYXS |
$86.55 Million | $86.55 Million | USA | $1.89 | -4.55% | +7.39% | 30.74 Million |
| 693 |
Tenaya Therapeutics Inc
NASDAQ:TNYA |
$86.26 Million | $86.26 Million | USA | $0.40 | -1.34% | +2.10% | 90.87 Million |
| 694 |
Pelthos Therapeutics Inc.
NYSE MKT:PTHS |
$85.55 Million | $85.55 Million | USA | $26.66 | -1.62% | -3.72% | 583.37K |
| 695 |
Cellectis SA
NASDAQ:CLLS |
$85.08 Million | $85.08 Million | USA | $1.17 | -7.14% | +20.81% | 2.50 Million |
| 696 |
Nyrada Inc
AU:NYR |
$84.93 Million | AU$120.03 Million | Australia | AU$0.49 | -1.01% | +4.26% | 6.66 Million |
| 697 |
Neuraxis, Inc.
NYSE MKT:NRXS |
$84.91 Million | $84.91 Million | USA | $7.38 | -0.67% | -11.62% | 4.63 Million |
| 698 |
Immutep Ltd ADR
NASDAQ:IMMP |
$84.03 Million | $84.03 Million | USA | $0.57 | -3.65% | +4.94% | 807.12 Million |
| 699 |
Novogenia AG
XETRA:7V0 |
$84.00 Million | €71.85 Million | Germany | €6.55 | +0.77% | -2.96% | 23.17K |
| 700 |
Brii Biosciences Limited
F:7SS |
$83.89 Million | €71.76 Million | Germany | €0.10 | +5.29% | +4.74% | 576.00 |
| 701 |
Synergy Innovation Co. Ltd
KQ:048870 |
$83.41 Million | ₩123.09 Billion | Korea | ₩1397.00 | +0.43% | -5.35% | 6.11 Million |
| 702 |
Artiva Biotherapeutics, Inc. Common Stock
NASDAQ:ARTV |
$82.80 Million | $82.80 Million | USA | $4.23 | -1.05% | -34.82% | 22.91 Million |
| 703 |
Bioton S.A.
WAR:BIO |
$82.71 Million | zł300.52 Million | Poland | zł3.50 | -2.51% | -5.53% | 1.02 Million |
| 704 |
Rallybio Corp
NASDAQ:RLYB |
$81.83 Million | $81.83 Million | USA | $15.41 | -3.63% | -4.99% | 406.08K |
| 705 |
Corbus Pharmaceuticals Holding
NASDAQ:CRBP |
$81.62 Million | $81.62 Million | USA | $4.22 | -0.71% | -1.52% | 20.95 Million |
| 706 |
Captor Therapeutics S.A.
WAR:CTX |
$81.41 Million | zł295.82 Million | Poland | zł53.70 | -2.19% | -8.36% | 197.47K |
| 707 |
Chunghwa Chemical Synthesis & Biotech Co Ltd
TW:1762 |
$80.94 Million | NT$2.57 Billion | Taiwan | NT$33.40 | -0.60% | -2.91% | 1.83 Million |
| 708 |
AlzeCure Pharma
ST:ALZCUR |
$80.38 Million | Skr746.94 Million | Sweden | Skr6.50 | -0.31% | -6.07% | 4.23 Million |
| 709 |
VIVANI MED.INC. NEW O.N.
F:U5P |
$79.34 Million | €67.86 Million | Germany | €0.97 | -2.02% | +1.04% | 0.00 |
| 710 |
PolyPid
NASDAQ:PYPD |
$77.73 Million | $77.73 Million | USA | $5.59 | -3.29% | +10.26% | 2.68 Million |
| 711 |
Aerovate Therapeutics Inc
NASDAQ:AVTE |
$77.68 Million | $77.68 Million | USA | $2.68 | +0.00% | +0.00% | 1.03 Million |
| 712 |
MAIA Biotechnology Inc.
NYSE MKT:MAIA |
$77.66 Million | $77.66 Million | USA | $1.28 | +0.00% | -5.88% | 12.98 Million |
| 713 |
Conexeu Sciences Inc. Common Stock
NASDAQ:CNXU |
$75.73 Million | $75.73 Million | USA | $2.83 | -1.74% | -15.02% | 8.28 Million |
| 714 |
ONDINE BIOMEDICAL INC.CDI
F:VF5 |
$75.33 Million | €64.44 Million | Germany | €0.14 | +54.10% | +55.80% | 0.00 |
| 715 |
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP |
$75.00 Million | $75.00 Million | USA | $5.28 | -1.68% | -2.76% | 22.97 Million |
| 716 |
GlycoNex
TWO:4168 |
$74.82 Million | NT$2.37 Billion | Taiwan | NT$21.45 | -0.23% | -1.15% | 2.09 Million |
| 717 |
PDS Biotechnology Corp
NASDAQ:PDSB |
$73.92 Million | $73.92 Million | USA | $1.55 | +1.97% | +25.00% | 267.72 Million |
| 718 |
Eyenovia Inc
NASDAQ:EYEN |
$73.30 Million | $73.30 Million | USA | $14.36 | +0.00% | +0.00% | 1.32 Million |
| 719 |
NeOnc Technologies Holdings, Inc. Common Stock
NASDAQ:NTHI |
$72.88 Million | $72.88 Million | USA | $3.12 | +2.97% | +7.59% | 3.57 Million |
| 720 |
Shanghai Haohai Biological Technology Co. Ltd
F:5HB |
$72.38 Million | €61.91 Million | Germany | €1.78 | +0.00% | +2.89% | 0.00 |
| 721 |
Pmv Pharmaceuticals Inc
NASDAQ:PMVP |
$72.17 Million | $72.17 Million | USA | $1.35 | -2.17% | -0.74% | 18.04 Million |
| 722 |
Recce Pharmaceuticals Ltd
AU:RCE |
$71.40 Million | AU$100.90 Million | Australia | AU$0.33 | +4.76% | -7.04% | 3.57 Million |
| 723 |
Nutriband Inc
NASDAQ:NTRB |
$70.50 Million | $70.50 Million | USA | $6.64 | +3.75% | +8.14% | 1.36 Million |
| 724 |
Oncopeptides AB
ST:ONCO |
$70.18 Million | Skr652.14 Million | Sweden | Skr1.71 | +3.07% | +1.24% | 176.44 Million |
| 725 |
Adocia
PA:ADOC |
$70.00 Million | €59.87 Million | France | €3.06 | -1.99% | +29.66% | 7.32 Million |
| 726 |
Rani Therapeutics Holdings Inc
NASDAQ:RANI |
$69.88 Million | $69.88 Million | USA | $0.61 | -1.61% | +0.07% | 12.42 Million |
| 727 |
Abionyx Pharma SA
PA:ABNX |
$69.87 Million | €59.76 Million | France | €1.69 | +1.07% | +3.04% | 2.62 Million |
| 728 |
Tenax Therapeutics Inc
NASDAQ:TENX |
$69.61 Million | $69.61 Million | USA | $1.86 | -1.06% | +14.11% | 52.10 Million |
| 729 |
MediciNova Inc
NASDAQ:MNOV |
$68.80 Million | $68.80 Million | USA | $1.40 | -4.76% | -0.71% | 4.58 Million |
| 730 |
Coeptis Therapeutics Inc
NASDAQ:COEP |
$68.21 Million | $68.21 Million | USA | $16.40 | +1.17% | +19.62% | 1.29 Million |
| 731 |
Milestone Pharmaceuticals Inc
NASDAQ:MIST |
$67.25 Million | $67.25 Million | USA | $0.79 | +4.25% | +13.56% | 22.42 Million |
| 732 |
Champions Oncology Inc
NASDAQ:CSBR |
$66.80 Million | $66.80 Million | USA | $4.81 | -2.24% | -0.82% | 232.55K |
| 733 |
Genexine Inc
KQ:095700 |
$66.73 Million | ₩98.46 Billion | Korea | ₩2165.00 | -3.78% | -14.76% | 4.98 Million |
| 734 |
Fortress Biotech Inc
NASDAQ:FBIO |
$66.44 Million | $66.44 Million | USA | $2.00 | +2.04% | +3.09% | 5.83 Million |
| 735 |
Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ:TELO |
$66.31 Million | $66.31 Million | USA | $0.96 | -4.53% | -5.47% | 2.84 Million |
| 736 |
Neumora Therapeutics, Inc.
NASDAQ:NMRA |
$65.99 Million | $65.99 Million | USA | $0.39 | -1.22% | -6.66% | 47.96 Million |
| 737 |
Nanoform Finland Plc
HE:NANOFH |
$65.50 Million | €56.03 Million | Finland | €0.65 | -1.95% | -10.41% | 1.58 Million |
| 738 |
Cognition Therapeutics Inc
NASDAQ:CGTX |
$65.27 Million | $65.27 Million | USA | $0.74 | -1.28% | -0.96% | 13.64 Million |
| 739 |
Alterity Therapeutics Limited
F:PBN |
$65.25 Million | €55.81 Million | Germany | €0.15 | +5.84% | +0.69% | 10.21K |
| 740 |
Kazia Therapeutics Ltd ADR
NASDAQ:KZIA |
$64.84 Million | $64.84 Million | USA | $11.82 | +2.52% | +18.20% | 5.85 Million |
| 741 |
Xlife Sciences AG
SW:XLS |
$64.31 Million | CHF50.87 Million | Switzerland | CHF8.82 | +2.56% | -5.77% | 144.22K |
| 742 |
Spero Therapeutics Inc
NASDAQ:SPRO |
$64.27 Million | $64.27 Million | USA | $1.11 | -5.13% | -5.13% | 11.10 Million |
| 743 |
Cingulate Inc
NASDAQ:CING |
$63.58 Million | $63.58 Million | USA | $5.19 | -1.14% | +11.37% | 2.70 Million |
| 744 |
Rein Therapeutics Inc
NASDAQ:RNTX |
$62.68 Million | $62.68 Million | USA | $0.73 | +1.67% | +16.29% | 10.72 Million |
| 745 |
Lytix Biopharma AS
OL:LYTIX |
$62.63 Million | Nkr595.21 Million | Norway | Nkr7.74 | +3.20% | -2.03% | 304.37K |
| 746 |
Cardiff Oncology Inc
NASDAQ:CRDF |
$62.35 Million | $62.35 Million | USA | $0.91 | +1.60% | -2.88% | 10.32 Million |
| 747 |
Island Pharmaceuticals Ltd
AU:ILA |
$61.87 Million | AU$87.44 Million | Australia | AU$0.33 | +0.00% | -4.41% | 5.36 Million |
| 748 |
iNtRON Biotechnology Inc
KQ:048530 |
$61.59 Million | ₩90.89 Billion | Korea | ₩2875.00 | -5.58% | -1.54% | 10.13 Million |
| 749 |
RenovoRx Inc
NASDAQ:RNXT |
$60.02 Million | $60.02 Million | USA | $1.49 | +4.56% | +21.14% | 10.29 Million |
| 750 |
Ikena Oncology Inc
NASDAQ:IKNA |
$59.90 Million | $59.90 Million | USA | $1.43 | +0.00% | +0.00% | 457.26K |
How Biotechnology Companies Are Ranked by Market Cap
Biotechnology companies are ranked by market cap, the latest share price multiplied by shares outstanding, with each company counted once at its primary listing.
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries